-
1
-
-
0033827496
-
Invitro susceptibility testing of filamentous fungi: Comparison of Etest and reference microdilution methods for determining itraconazole MICs
-
Pfaller MA, Messer SA, Mills K, Bolmström A. Invitro susceptibility testing of filamentous fungi: comparison of Etest and reference microdilution methods for determining itraconazole MICs. J ClinMicrobiol. 2000; 38: 3359-3361.
-
(2000)
J ClinMicrobiol
, vol.38
, pp. 3359-3361
-
-
Pfaller, M.A.1
Messer, S.A.2
Mills, K.3
Bolmström, A.4
-
2
-
-
0032944880
-
Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds
-
Szekely A, Johnson EM, Warnock DW. Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J ClinMicrobiol. 1996; 37: 1480-1483.
-
(1996)
J ClinMicrobiol
, vol.37
, pp. 1480-1483
-
-
Szekely, A.1
Johnson, E.M.2
Warnock, D.W.3
-
3
-
-
0003443233
-
National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi
-
Wayne PA. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard. 2002; 28: 14.
-
(2002)
Approved standard.
, vol.28
, pp. 14
-
-
Wayne, P.A.1
-
4
-
-
0035217138
-
Antifungal susceptibility testing. New technology and clinical applications
-
Pfaller MA, Yu WL. Antifungal susceptibility testing. New technology and clinical applications. Infect Dis Clin North Am. 2001; 15: 1227-1261.
-
(2001)
Infect Dis Clin North Am.
, vol.15
, pp. 1227-1261
-
-
Pfaller, M.A.1
Yu, W.L.2
-
5
-
-
0036205764
-
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillusspp. and other filamentous fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000
-
Pfaller MA, Messer SA, Hollis RJ, Jones RN. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillusspp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrob Agents Chemother. 2002; 46: 1032-1037.
-
(2002)
Antimicrob Agents Chemother.
, vol.46
, pp. 1032-1037
-
-
Pfaller, M.A.1
Messer, S.A.2
Hollis, R.J.3
Jones, R.N.4
-
6
-
-
19944432456
-
Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: Surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003
-
Hsueh PR, Lau YJ, Chuang YC, Wan JH, Huang WK, Shyr JM, et al. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003. Antimicrob Agents Chemother. 2005; 49: 512-517.
-
(2005)
Antimicrob Agents Chemother.
, vol.49
, pp. 512-517
-
-
Hsueh, P.R.1
Lau, Y.J.2
Chuang, Y.C.3
Wan, J.H.4
Huang, W.K.5
Shyr, J.M.6
-
7
-
-
73649092418
-
Molecular Identification and In-Vitro Susceptibility of Candida albicans and C. dubliniensis Isolated from Immunocompromised Patients
-
Badiee P, Alborzi A, Shakiba E, Ziyaeyan M, Rasuli M. Molecular Identification and In-Vitro Susceptibility of Candida albicans and C. dubliniensis Isolated from Immunocompromised Patients. IRCMJ. 2009; 11: 391-397.
-
(2009)
IRCMJ.
, vol.11
, pp. 391-397
-
-
Badiee, P.1
Alborzi, A.2
Shakiba, E.3
Ziyaeyan, M.4
Rasuli M.x5
-
8
-
-
79958058392
-
Susceptibility of Candida species isolated from immunocompromised patients to antifungal agents
-
Badiee P, Alborzi A, ShakibaE, Farshad S, Japoni A. Susceptibility of Candida species isolated from immunocompromised patients to antifungal agents. EMHJ. 2011; 17: 425-430.
-
(2011)
EMHJ.
, vol.17
, pp. 425-430
-
-
Badiee, P.1
Alborzi, A.2
Shakiba, E.3
Farshad, S.4
Japoni, A.5
-
9
-
-
0035007179
-
Optimal susceptibility testing conditions for detection of azole resistance in Aspergillusspp; NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards
-
Espinel-Ingroff A, Bartlett M, Chaturvedi V, Ghannoum M, Hazen KC, Pfaller MA, et al. Optimal susceptibility testing conditions for detection of azole resistance in Aspergillusspp; NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards. Antimicrob Agents Chemother. 2001; 45: 1828-1835.
-
(2001)
Antimicrob Agents Chemother.
, vol.45
, pp. 1828-1835
-
-
Espinel-Ingroff, A.1
Bartlett, M.2
Chaturvedi, V.3
Ghannoum, M.4
Hazen, K.C.5
Pfaller, M.A.6
-
10
-
-
0033978008
-
Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection
-
Johnson EM, Oakley KL, Radford SA, Moore CB, Warn P, Warnock DW, et al. Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection. J Antimicrob Chemother. 2000; 45: 85-93.
-
(2000)
J Antimicrob Chemother.
, vol.45
, pp. 85-93
-
-
Johnson, E.M.1
Oakley, K.L.2
Radford, S.A.3
Moore, C.B.4
Warn, P.5
Warnock, D.W.6
-
11
-
-
0037335806
-
In vitro susceptibility testing of Aspergillus spp: Comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs
-
Pfaller JB, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. In vitro susceptibility testing of Aspergillus spp: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs. J Clin Microbiol. 2003; 41: 1126-1129.
-
(2003)
J Clin Microbiol.
, vol.41
, pp. 1126-1129
-
-
Pfaller, J.B.1
Messer, S.A.2
Hollis, R.J.3
Diekema, D.J.4
Pfaller, M.A.5
-
12
-
-
0036701634
-
Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species
-
Meletiadis J, Mouton JW, Meis JF, Bouman BA, Verweij PE. Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol. 2002; 40: 2876-2885.
-
(2002)
J Clin Microbiol.
, vol.40
, pp. 2876-2885
-
-
Meletiadis, J.1
Mouton, J.W.2
Meis, J.F.3
Bouman, B.A.4
Verweij, P.E.5
-
13
-
-
0036259959
-
E-test method for testing susceptibilities of Aspergillusspecies to the new triazoles voriconazole and posaconazole and to established antifungal agents: Comparison with NCCLS broth microdilution method
-
Espinel-Ingroff A, Rezusta A. E-test method for testing susceptibilities of Aspergillusspecies to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method. J Clin Microbiol. 2002; 40: 2101-2107.
-
(2002)
J Clin Microbiol
, vol.40
, pp. 2101-2107
-
-
Espinel-Ingroff, A.1
Rezusta, A.2
|